ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma. - Moertel CL; Hirbe AC; Shuhaiber HH; Bielamowicz K; Sidhu A; Viskochil D; Weber MD; Lokku A; Smith LM; Foreman NK; Hajjar FM; McNall-Knapp RY; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)